Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Keratin 43, pseudogene (KRT43P) is a non-functional, pseudogenized member of the keratin gene family, which consists of intermediate filament proteins and keratin-associated proteins (KAPs) involved in the structural integrity of hair, skin, and epithelia in mammals[1][2][3]. Pseudogenes are gene sequences that have lost their protein-coding potential due to disruptive mutations and are not transcribed into functional proteins[1][2]. “KRT43P” appears to be a misapplied name, as it does not conform to standard keratin or keratin-associated protein nomenclature, and is not recognized as a protein-coding gene nor as a therapeutic or diagnostic target; it likely refers to a predicted or hypothetical gene classified as a non-functional relic, not a molecular target in disease or drug discovery. Notes on correctness and target status: - The standard human keratin gene system does not include a “KRT43” functional gene; “KRTAP” designations are for keratin-associated proteins, and the “p” suffix denotes a pseudogene[2][1]. The entity described as “KRT43P” is strictly a pseudogene, not a druggable or biologically functional entity, and is not considered a classical molecular target[1][2]. - There is no evidence for disease association, biological function, or therapeutic relevance for “KRT43P”; it is not referenced in genetic, proteomic, or clinical drug databases as a target. - If the query refers specifically to the canonical keratin family, valid targets would be properly named proteins like “Keratin, type I cytoskeletal 10 (KRT10)” or similar[3]. The current entry is non-canonical and non-actionable. Summary: - Keratin 43, pseudogene (KRT43P) is a non-functional gene remnant, not a molecular target, with no biological role, disease association, or therapeutic relevance[1][2]. - The abbreviation and name do not correspond to an actionable or canonical gene, making this entry incorrect as a molecular target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Keratin 43, pseudogene (KRT43P).